| Eliapixant 25 mg BID n = 37 (100%) | Eliapixant 75 mg BID n = 37 (100%) | Eliapixant 150 mg BID n = 36 (100%) | Placebo n = 36 (100%) | Elagolix 150 mg n = 37 (100%) | Total n = 183 (100%) |
---|---|---|---|---|---|---|
Race | Â | Â | Â | Â | Â | Â |
 White | 26 (70.3%) | 26 (70.3%) | 25 (69.4%) | 23 (63.9%) | 35 (94.6%) | 135 (73.8%) |
 Black or African American | 0 | 1 (2.7%) | 2 (5.6%) | 2 (5.6%) | 0 | 5 (2.7%) |
 Asian | 11 (29.7%) | 10 (27.0%) | 9 (25.0%) | 11 (30.6%) | 0 | 41 (22.4%) |
 Not reported | 0 | 0 | 0 | 0 | 2 (5.4%) | 2 (1.1%) |
Age (years) | 33.41 (7.07) | 36.32 (7.60) | 35.75 (7.11) | 35.58 (7.17) | 32.19 (6.64) | 34.64 (7.22) |
Age group | Â | Â | Â | Â | Â | Â |
 < 30 years | 11 (29.7%) | 7 (18.9%) | 7 (19.4%) | 10 (27.8%) | 14 (37.8%) | 49 (26.8%) |
 30–40 years | 20 (54.1%) | 18 (48.6%) | 21 (58.3%) | 14 (38.9%) | 19 (51.4%) | 92 (50.3%) |
 > 40–55 years | 6 (16.2%) | 12 (32.4%) | 8 (22.2%) | 12 (33.3%) | 4 (10.8%) | 42 (23.0%) |
Main eye color | Â | Â | Â | Â | Â | Â |
 Green | 4 (10.8%) | 8 (21.6%) | 7 (19.4%) | 8 (22.2%) | 12 (32.4%) | 39 (21.3%) |
 Blue | 8 (21.6%) | 7 (18.9%) | 6 (16.7%) | 5 (13.9%) | 10 (27.0%) | 36 (19.7%) |
 Gray | 1 (2.7%) | 2 (5.4%) | 3 (8.3%) | 1 (2.8%) | 2 (5.4%) | 9 (4.9%) |
 Hazel | 1 (2.7%) | 1 (2.7%) | 4 (11.1%) | 4 (11.1%) | 0 | 10 (5.5%) |
 Brown | 23 (62.2%) | 19 (51.4%) | 16 (44.4%) | 18 (50.0%) | 13 (35.1%) | 89 (48.6%) |
Natural hair color (at age 18) | Â | Â | Â | Â | Â | Â |
 Red | 0 | 1 (2.7%) | 1 (2.8%) | 0 | 0 | 2 (1.1%) |
 Blonde | 7 (18.9%) | 4 (10.8%) | 8 (22.2%) | 7 (19.4%) | 8 (21.6%) | 34 (18.6%) |
 Light brown | 9 (24.3%) | 10 (27.0%) | 8 (22.2%) | 8 (22.2%) | 14 (37.8%) | 49 (26.8%) |
 Dark brown | 10 (27.0%) | 13 (35.1%) | 7 (19.4%) | 6 (16.7%) | 14 (37.8%) | 50 (27.3%) |
 Black | 11 (29.7%) | 9 (24.3%) | 12 (33.3%) | 15 (41.7%) | 1 (2.7%) | 48 (26.2%) |
Body mass index (kg/m2) | 25.08 (6.53) | 26.01 (5.17) | 25.34 (5.24) | 25.61 (6.18) | 25.64 (6.44) | 25.53 (5.89) |
Mean worst pain | 6.09 (1.73) | 6.05 (1.78) | 6.63 (1.62) | 5.89 (1.93) | 6.38 (1.78) | 6.21 (1.77) |
Non-menstrual pelvic pain | 5.85 (1.81) | 5.80 (1.95) | 6.45 (1.78) | 5.62 (2.05) | 6.18 (1.86) | 5.98 (1.89) |
Dysmenorrhea | 7.16 (1.60) | 6.91 (1.55) | 7.38 (1.39) | 7.00 (1.77) | 7.29 (1.84) | 7.15 (1.63) |